Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 13,400 shares, a decline of 86.2% from the January 15th total of 96,900 shares. Based on an average daily volume of 142,500 shares, the short-interest […]